Literature DB >> 1967654

Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid.

P H Nelson1, E Eugui, C C Wang, A C Allison.   

Abstract

The syntheses and immunosuppressive bioassays of 12 side-chain variants of mycophenolic acid are described. The compounds were made either from mycophenolic acid itself or from 5-(chloromethyl)-1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxoisoben zofuran, a versatile intermediate for the synthesis of diverse side-chain variants. Replacement of the methylated E double bond of the natural product with a triple bond, a Z double bond, a saturated bond, or a sulfur atom, with overall chain lengths equal to or greater than that of mycophenolic acid, produced compounds devoid of significant activity. Replacement of the side-chain double bond with difluoro, dibromo, or unsubstituted cyclopropane rings also removed most activity. Replacement of the double bond with an allenic linkage yielded a compound with about one-fifth of the immunosuppressive activity of mycophenolic acid. Some possible causes for the unusual specificity of structure and activity are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967654     DOI: 10.1021/jm00164a057

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

2.  Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.

Authors:  M Tanabe; S Todo; N Murase; W Irish; H Miyazawa; S Fujisaki; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 3.  The design and development of an immunosuppressive drug, mycophenolate mofetil.

Authors:  A C Allison; E M Eugui
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

Authors:  N Murase; T E Starzl; A J Demetris; L Valdivia; M Tanabe; D Cramer; L Makowka
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

5.  Biotransformations of imbricatolic acid by Aspergillus niger and Rhizopus nigricans cultures.

Authors:  Guillermo Schmeda-Hirschmann; Carlos Aranda; Marcela Kurina; Jaime A Rodríguez; Cristina Theoduloz
Journal:  Molecules       Date:  2007-05-21       Impact factor: 4.411

6.  Canine laryngeal transplantation: preliminary studies and a new heterotopic allotransplantation model.

Authors:  J P Anthony; D B Allen; P P Trabulsy; M Mahdavian; S J Mathes
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.

Authors:  Zhengrong Guan; Matthew I Giddens; David A Osmond; Anthony K Cook; Janet L Hobbs; Shali Zhang; Tatsuo Yamamoto; Jennifer S Pollock; David M Pollock; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-26

8.  Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.

Authors:  M Tanabe; S Todo; N Murase; W Irish; H Miyazawa; S Fujisaki; T E Starzl
Journal:  Transplantation       Date:  1994-07-15       Impact factor: 4.939

Review 9.  A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.

Authors:  Steve P H Alexander; Jane F Armstrong; Anthony P Davenport; Jamie A Davies; Elena Faccenda; Simon D Harding; Francesca Levi-Schaffer; Janet J Maguire; Adam J Pawson; Christopher Southan; Michael Spedding
Journal:  Br J Pharmacol       Date:  2020-07-19       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.